Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC)
Ying Liu1, Hanying Chen1, Weinian Shou2
1Riley Heart Research Center, Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Defects in myofibrillogenesis and polarization of trabecular cardiomyocytes may cause ventricular noncompaction, a condition linked to left ventricular noncompaction (LVNC) cardiomyopathy.
Area of Science:
- Cardiovascular Development
- Cardiac Morphogenesis
- Cardiomyopathy Research
Background:
- Ventricular trabeculation and compaction are crucial for heart development.
- Reduced trabeculation leads to hypoplastic walls, embryonic heart failure, and lethality.
- Arrested ventricular compaction causes left ventricular noncompaction (LVNC), a common pediatric cardiomyopathy.
Purpose of the Study:
- To review findings from genetically engineered mouse models of ventricular noncompaction.
- To propose a unifying pathogenic mechanism for ventricular noncompaction.
Main Methods:
- Review of recent scientific literature.
- Analysis of genetically engineered mouse models.
- Development of a pathogenetic model for ventricular noncompaction.
Main Results:
- Genetically engineered mouse models provide insights into ventricular development.
- Defects in myofibrillogenesis and cardiomyocyte polarization are implicated.
- These defects represent a common pathway in ventricular noncompaction.
Conclusions:
- Myofibrillogenesis and polarization defects in trabecular cardiomyocytes are proposed as the underlying cause of ventricular noncompaction.
- This model integrates findings from various genetic studies.
- Understanding this mechanism is vital for LVNC research and potential therapies.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Common Ion Effect
Cardiomyopathy V: Interprofessional Care

